SCHEMBL7510342

SCHEMBL7510342

CCCC[SiH2]OC(c1ccccc1)(c1ccccc1)c1cc(C(=O)OCC)cc(C(=O)OCC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CNR2 P34972 1/20 0.39
CA12 O43570 3/20 0.38
CA9 Q16790 3/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA7 P43166 2/20 0.38
CA14 Q9ULX7 2/20 0.38
SMN1; SMN2 Q16637 6/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP1A2 P05177 1/20 0.38
HPGD P15428 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 2/20 0.37
TSHR P16473 1/20 0.37
ALDH1A1 P00352 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7447426 0.79 PRKCA (0.36) MEN1KMT2A
SCHEMBL7451104 0.78 UNG (0.36) CA2NPC1RAB9ACYP2C9HPGD
Ethyl Benzoate SCHEMBL27622572 0.70 LMNA (0.67) MEN1KMT2ACA12CA9CA1
Ethyl Benzoate SCHEMBL27281972 0.68 LMNA (0.65) MEN1KMT2ACA12CA9CA1
Ethyl Benzoate SCHEMBL30886688 0.68 LMNA (0.68) MEN1KMT2ACA12CA9CA1
Ethyl Benzoate SCHEMBL27940401 0.68 LMNA (0.68) MEN1KMT2ACA12CA9CA1
SCHEMBL1664013 0.67 CA12 (0.75) MEN1KMT2ACA12CA9CA1
SCHEMBL3510029 0.67 RAB9A (0.57) MEN1KMT2ACA12CA9CA1
SCHEMBL20546618 0.67 MEN1 (0.51) MEN1KMT2ANPC1RAB9ACYP1A2
SCHEMBL12813482 0.67 KIF11 (0.50) SMN1; SMN2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1192127-A1 SUBSTITUTED BENZAMIDE INHIBITORS OF RHINOVIRUS 3C PROTEASE Agouron Pharmaceuticals, Inc. (US) 2002-04-03 EP disclosed
WO-2000078708-A1 SUBSTITUTED BENZAMIDE INHIBITORS OF RHINOVIRUS 3C PROTEASE AGOURON PHARMACEUTICALS, INC. (US) 2000-12-28 WO disclosed